Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

NEXT STORY
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Sorrento Therapeutics, Inc. (SRNE)
PREV STORY
Ziopharm Oncology Announces Management Transition
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sunesis to Host Conference Call on March 9th to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News

Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split

Los Angeles, California, March 01, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

author_avatar
NASDAQ Market News

Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research

Results Show that Primary Care Physicians Obtained Improved Outcomes for Patients with Depression When ...

author_avatar
NASDAQ Market News